Rh

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
THE MARK S. DEMILIO REVOCABLE TRUST	Director	2026-07-10	2K shares	$412K
GARY FRIEDMAN	Officer, Director, 10% Stockholder	2026-07-08	48K shares	$7.65M
GARY FRIEDMAN	Officer, Director, 10% Stockholder	2026-07-07	8K shares	$1.31M
GARY FRIEDMAN	Officer, Director, 10% Stockholder	2026-07-06	69K shares	$11.71M
DEMILIO MARK S	Director	2026-06-18	3K shares	$447K
DEMILIO MARK S	Director	2026-06-16	2K shares	$330K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

Active 5%+ Holders

Data as of 2026-07-09

Reporting Person	Type	Filing Date	Shares	% of Class
Gary G. Friedman	13D/A	2026-07-09	4.93M	23.9%

View all Schedule 13D/13G filings

Material Events (8-K)

Filings (14d)

Data as of 2026-07-08

2026-07-08

No AI summary for this filing type

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding RH (RH)?

Major stakeholders currently include FMR LLC ($390.9M), Susquehanna International Group, LLP ($316.9M), Alyeska Investment Group, L.P. ($228.8M). Based on the latest 13F filings, there are a total of 377 tracked investment funds and institutions maintaining positions in RH.

What is the overall institutional sentiment toward RH recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $810.9M, driven by 213 managers accumulating shares while 194 reduced their exposure.

Which institutions have been selling or reducing their RH positions?

In the latest period, 109 funds trimmed their holdings, and 85 managers completely exited their positions. The aggregate reported sell value was $2.2B.

Are there any notable investors adding RH to their portfolios?

Yes, buying activity remains notable. 62 institutions opened new positions in {ticker}, and 151 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.1B.